Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2006-7-17
pubmed:abstractText
This study sought to analyze the cost of percutaneous coronary interventions with use of sirolimus-eluting stents (SES) or paclitaxel-eluting stents (PES) in patients at high risk of restenosis.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1558-3597
pubmed:author
pubmed:issnType
Electronic
pubmed:day
18
pubmed:volume
48
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
262-7
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:16843172-Aged, pubmed-meshheading:16843172-Angioplasty, Balloon, Coronary, pubmed-meshheading:16843172-Cardiovascular Agents, pubmed-meshheading:16843172-Coronary Disease, pubmed-meshheading:16843172-Coronary Restenosis, pubmed-meshheading:16843172-Cost Savings, pubmed-meshheading:16843172-Costs and Cost Analysis, pubmed-meshheading:16843172-Diabetic Angiopathies, pubmed-meshheading:16843172-Female, pubmed-meshheading:16843172-Germany, pubmed-meshheading:16843172-Health Services, pubmed-meshheading:16843172-Hospital Costs, pubmed-meshheading:16843172-Hospitalization, pubmed-meshheading:16843172-Humans, pubmed-meshheading:16843172-Male, pubmed-meshheading:16843172-Middle Aged, pubmed-meshheading:16843172-Paclitaxel, pubmed-meshheading:16843172-Randomized Controlled Trials as Topic, pubmed-meshheading:16843172-Sirolimus
pubmed:year
2006
pubmed:articleTitle
Cost analysis from two randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in high-risk patients with coronary artery disease.
pubmed:affiliation
Deutsches Herzzentrum, Technische Universität; Munich, Germany.
pubmed:publicationType
Journal Article, Comparative Study